<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>40(6)</volume><submitter>Erukainure OL</submitter><funding>The World Academy of Sciences</funding><pubmed_abstract>The global spread of the coronavirus infections disease - 2019 (COVID-19) and the search for new drugs from natural products particularly from plants are receiving much attention recently. In this study, the therapeutic potential of a new iridoid glycoside isolated from the leaves of &lt;i>Clerodendrum volubile&lt;/i> against COVID-19 was investigated. Harpagide 5-O-β-D-glucopyranoside (HG) was isolated, characterised and investigated for its druglikeness, optimized geometry, and pharmacokinetics properties. Its immunomodulatory was determined by chemiluminescence assay using polymorphonuclear neutrophils (PMNs) in addition to T-cell proliferation assay. &lt;i>In silico&lt;/i> analysis was used in determining its molecular interaction with severe acute respiratory syndrome coronavirus-2 (SARS-COV-2). </pubmed_abstract><journal>Journal of biomolecular structure &amp; dynamics</journal><pagination>2475-2488</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7651195</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Targeting the initiation and termination codons of SARS-CoV-2 spike protein as possible therapy against COVID-19: the role of novel harpagide 5-O-β-D-glucopyranoside from &lt;i>Clerodendrum volubile&lt;/i> P Beauv. (Labiatae).</pubmed_title><pmcid>PMC7651195</pmcid><pubmed_authors>Ebhuoma OO</pubmed_authors><pubmed_authors>Ibeji CU</pubmed_authors><pubmed_authors>Muhammad A</pubmed_authors><pubmed_authors>Atolani O</pubmed_authors><pubmed_authors>Katsayal SB</pubmed_authors><pubmed_authors>Mesaik MA</pubmed_authors><pubmed_authors>Erukainure OL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting the initiation and termination codons of SARS-CoV-2 spike protein as possible therapy against COVID-19: the role of novel harpagide 5-O-β-D-glucopyranoside from &lt;i>Clerodendrum volubile&lt;/i> P Beauv. (Labiatae).</name><description>The global spread of the coronavirus infections disease - 2019 (COVID-19) and the search for new drugs from natural products particularly from plants are receiving much attention recently. In this study, the therapeutic potential of a new iridoid glycoside isolated from the leaves of &lt;i>Clerodendrum volubile&lt;/i> against COVID-19 was investigated. Harpagide 5-O-β-D-glucopyranoside (HG) was isolated, characterised and investigated for its druglikeness, optimized geometry, and pharmacokinetics properties. Its immunomodulatory was determined by chemiluminescence assay using polymorphonuclear neutrophils (PMNs) in addition to T-cell proliferation assay. &lt;i>In silico&lt;/i> analysis was used in determining its molecular interaction with severe acute respiratory syndrome coronavirus-2 (SARS-COV-2). </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-05-08T13:36:55.132Z</modification><creation>2020-11-19T13:40:25Z</creation></dates><accession>S-EPMC7651195</accession><cross_references><pubmed>33140706</pubmed><doi>10.1080/07391102.2020.1840439</doi></cross_references></HashMap>